The recent use of Swietenia mahagoni (L.) Jacq. as antidiabetes type 2 phytomedicine: A systematic review

• Published in: Heliyon Vol. 6; no. 3; p. e03536
• Main Authors: Sukardiman, Ervina, Martha
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.03.2020; Elsevier
• Subjects: alpha-amylase; antioxidants; bark; biomarkers; blood glucose; chemotaxonomy; Diabetes; drugs; epinephrine; flavanols; glycemic effect; Hypoglycemic; India; Indonesia; limonoids; liver; Mahogany; Meliaceae; phenolic compounds; saponins; Swietenia macrophylla; Swietenia mahagoni; Swietenia sp; systematic review; toxicity; Toxicology; traditional medicine; wood; India; Indonesia; Toxicology; Hypoglycemic; Diabetes; Mahogany; Swietenia sp; Meliaceae

Natural resources provide more efficient and safer alternatives in managing diabetes compare to the synthetic oral anti diabetes (OAD). The plants not only have hypoglycemic effect, but also prevent its complications; in which no synthetic drugs provide of both properties. Among antidiabetes plants,...